 MELVILLE, N.Y., Jan. 06, 2022 GLOBE NEWSWIRE -- BioRestorative Therapies, Inc. the Company or BioRestorative NASDAQ: BRTX , a life sciences company focused on stem cell-based therapies, today announced that Lance Alstodt, its Chief Executive Officer, will present a corporate overview at the H.C. Wainwright BioConnect 2022 Conference, being held virtually from January 10-13, 2022. 